220 related articles for article (PubMed ID: 9861499)
1. Efficacy of clindamycin hydrochloride capsules for the treatment of deep pyoderma due to Staphylococcus intermedius infection in dogs.
Scott DW; Beningo KE; Miller WH; Rothstein E
Can Vet J; 1998 Dec; 39(12):753-6. PubMed ID: 9861499
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of orbifloxacin tablets for the treatment of superficial and deep pyoderma due to Staphylococcus intermedius infection in dogs.
Scott DW; Peters J; Miller WH
Can Vet J; 2006 Oct; 47(10):999-1002. PubMed ID: 17078249
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of once-daily clindamycin hydrochloride in the treatment of superficial bacterial pyoderma in dogs.
Bloom PB; Rosser EJ
J Am Anim Hosp Assoc; 2001; 37(6):537-42. PubMed ID: 11716027
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs.
Scott DW; Miller WH; Cayatte SM; Bagladi MS
Can Vet J; 1994 Oct; 35(10):617-21. PubMed ID: 7994702
[TBL] [Abstract][Full Text] [Related]
5. Further studies on the efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs.
Scott DW; Miller WH; Rothstein SE; Bagladi MS
Can Vet J; 1996 Oct; 37(10):617-8. PubMed ID: 8896878
[No Abstract] [Full Text] [Related]
6. A comparison of lincomycin hydrochloride and clindamycin hydrochloride in the treatment of superficial pyoderma in dogs.
Harvey RG; Noble WC; Ferguson EA
Vet Rec; 1993 Apr; 132(14):351-3. PubMed ID: 8488640
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the clinical efficacy of marbofloxacin (Zeniquin) tablets for the treatment of canine pyoderma: an open clinical trial.
Paradis M; Abbey L; Baker B; Coyne M; Hannigan M; Joffe D; Pukay B; Trettien A; Waisglass S; Wellington J
Vet Dermatol; 2001 Jun; 12(3):163-9. PubMed ID: 11420932
[TBL] [Abstract][Full Text] [Related]
8. Clindamycin hydrochloride and clavulanate-amoxycillin in the treatment of canine superficial pyoderma.
Littlewood JD; Lakhani KH; Paterson S; Wood JL; Chanter N
Vet Rec; 1999 Jun; 144(24):662-5. PubMed ID: 10404604
[TBL] [Abstract][Full Text] [Related]
9. Posologic evaluation of clindamycin, using a canine model of posttraumatic osteomyelitis.
Braden TD; Johnson CA; Gabel CL; Lott GA; Caywood DD
Am J Vet Res; 1987 Jul; 48(7):1101-5. PubMed ID: 3631693
[TBL] [Abstract][Full Text] [Related]
10. Rifampicin treatment of canine pyoderma due to multidrug-resistant meticillin-resistant staphylococci: a retrospective study of 32 cases.
De Lucia M; Bardagi M; Fabbri E; Ferreira D; Ferrer L; Scarampella F; Zanna G; Fondati A
Vet Dermatol; 2017 Apr; 28(2):171-e36. PubMed ID: 28025853
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of clindamycin in the treatment of Staphylococcus aureus osteomyelitis in dogs.
Braden TD; Johnson CA; Wakenell P; Tvedten HW; Mostosky UV
J Am Vet Med Assoc; 1988 Jun; 192(12):1721-5. PubMed ID: 3410788
[TBL] [Abstract][Full Text] [Related]
12. Epidemiosurveillance of antimicrobial compound resistance of Staphylococcus intermedium clinical isolates from canine pyodermas.
Pellerin JL; Bourdeau P; Sebbag H; Person JM
Comp Immunol Microbiol Infect Dis; 1998 Apr; 21(2):115-33. PubMed ID: 9611682
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the clinical efficacy of pradofloxacin tablets for the treatment of canine pyoderma.
Restrepo C; Ihrke PJ; White SD; Spiegel IB; Affolter VK
J Am Anim Hosp Assoc; 2010; 46(5):301-11. PubMed ID: 20810550
[TBL] [Abstract][Full Text] [Related]
14. Masked, controlled study to investigate the efficacy of a Staphylococcus intermedius autogenous bacterin for the control of canine idiopathic recurrent superficial pyoderma.
Curtis CF; Lamport AI; Lloyd DH
Vet Dermatol; 2006 Jun; 17(3):163-8. PubMed ID: 16674730
[TBL] [Abstract][Full Text] [Related]
15. Canine superficial bacterial pyoderma: evaluation of skin surface sampling methods and antimicrobial susceptibility of causal Staphylococcus isolates.
Ravens PA; Vogelnest LJ; Ewen E; Bosward KI; Norris JM
Aust Vet J; 2014 May; 92(5):149-55. PubMed ID: 24766044
[TBL] [Abstract][Full Text] [Related]
16. Multidrug- and methicillin resistant Staphylococcus pseudintermedius as a cause of canine pyoderma: a case report.
Vincze S; Paasch A; Walther B; Ruscher C; Lübke-Becker A; Wieler LH; Barbara K
Berl Munch Tierarztl Wochenschr; 2010; 123(9-10):353-8. PubMed ID: 21038805
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of cefadroxil in the treatment of bacterial dermatitis in dogs.
Angarano DW; MacDonald JM
J Am Vet Med Assoc; 1989 Jan; 194(1):57-9. PubMed ID: 2914788
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with methicillin-resistant versus methicillin-susceptible Staphylococcus pseudintermedius infection in dogs.
Weese JS; Faires MC; Frank LA; Reynolds LM; Battisti A
J Am Vet Med Assoc; 2012 Jun; 240(12):1450-5. PubMed ID: 22657928
[TBL] [Abstract][Full Text] [Related]
19. Pradofloxacin in the treatment of canine deep pyoderma: a multicentred, blinded, randomized parallel trial.
Mueller RS; Stephan B
Vet Dermatol; 2007 Jun; 18(3):144-51. PubMed ID: 17470228
[TBL] [Abstract][Full Text] [Related]
20. Guidelines on the use of systemic aminoglycosides in veterinary dermatology.
Noli C; Morris D
Vet Dermatol; 2011 Aug; 22(4):379-80. PubMed ID: 21645142
[No Abstract] [Full Text] [Related]
[Next] [New Search]
